News / USA

US Developing Radiation Sickness Drug

Ex-Rad could be used before or after exposure

Evacuees are screened for radiation contamination at a testing center Tuesday, March 15, 2011, in Koriyama city, Fukushima Prefecture, northern Japan, four days after a massive earthquake and tsunami struck the country's north east coast.
Evacuees are screened for radiation contamination at a testing center Tuesday, March 15, 2011, in Koriyama city, Fukushima Prefecture, northern Japan, four days after a massive earthquake and tsunami struck the country's north east coast.

Multimedia

Vidushi Sinha

The serious radiation leaks at Japan's damaged Fukushima-Daiichi nuclear power plant have reawakened public fears about radiation sickness. But what if there were a drug that could not only protect people from dangerous levels of radiation exposure but also heal those actually exposed to damaging nuclear radiation?

Researchers say they are developing such a drug - one that can both prevent and repair human cell damage from all types of radiation exposure.

Such a healing medication has the potential to lessen panic and fear generated by catastrophic reactor accidents. Plant workers trying to make repairs near a crippled reactor's radioactive core might be less fearful if they could take a pill to repair their own radiation-damaged cells.

Ramesh Kumar, the CEO of a U.S. drug research firm called Onconova, says his company has just such a wonder drug in the works.

The company has been collaborating on the drug, called Ex-Rad, with scientists at a U.S. Defense Department research laboratory. Kumar says early animal trials have been promising.

“Ex-Rad is a drug which is effective in saving a cell damaged by radiation," he says, "and we have found that it can be given in advance of exposure to radiation up to a day ahead or it can be given up to a day after the exposure to radiation.”

There are existing antidotes for radiation exposure which have been approved by the federal Food and Drug Administration (FDA). Potassium iodide, also known as the radiation pill, prevents the body's absorption of the radioactive iodine present in reactor emissions. For a person poisoned by radioactive isotopes such as plutonium and cesium - types of radiation being released from the Fukushima reactors - FDA-approved drugs such as Prussian Blue capsules can quickly flush radioactive elements from the body. However, right now there are no drugs specifically for treating radiation sickness itself.

The Armed Forces Radiobiology Research Institute has been leading the Pentagon's quest for a more effective antidote to radiation sickness, which has a wide range of symptoms.

“The symptoms of acute radiation sickness will be just exactly like a terrible flu," says Col. Andrew Huff, a spokesman for the research institute. "The person would have headache. They would feel very tired. They would have little bit of fever. They might have some vomiting at higher doses all of this and more but at survivable doses it would come on within 24 to 36 hours."

According to Huff, the body loses its platelet and neutrophil supply and people can eventually die of bleeding. He says the Pentagon's search for radiation sickness treatments is intensifying.

“The other more vexing problem, the one that we really have to worry about for larger numbers of people - if there were nuclear terrorism - is how much external ionizing penetrating radiation a person would get after a nuclear detonation."

To combat such a crisis - or to treat people exposed to radiation from a damaged nuclear reactor - the Department of Defense and Onconova have collaborated on the development of Ex-Rad.

“FDA has devised a development path for drugs like Ex-Rad which involves clinical trials, animal studies, and additional controls for manufacturing and we are in the process of completing these studies," says Kumar, whose company is developing Ex-Rad. "We started this process in 2008 under and FDA's Investigational New Drug Exemption. We have carried out clinical studies in human subjects for safety and we are in the process of continuing to do animal efficacy studies so once all of these studies are completed we can get an approval for specific indication. It could be prophylactic use before - or after - exposure.  It could be injectable or oral.”

Kumar says Ex-Rad won't be available for at least another two or three years. In the meantime, government officials warn the public to be cautious about the growing number of claims being made on the Internet for anti-radiation drugs that purport to be miracle cures.

You May Like

UN: 1 Million Somalis at Risk of Hunger

Group warns region is in dire need of humanitarian aid, with at least 200,000 children under age of five acutely malnourished as drought hits southern, central part of nation More

Human Rights Groups Allege Supression of Freedoms in Thailand

Thailand’s military, police have suppressed release of independent report assessing human rights in kingdom during first 100 days of latest coup More

Jennifer Lawrence Contacts FBI After Nude Photos Hacked

'Silver Linings Playbook' actress' photos were posted on image-sharing forum 4chan; Federal Bureau of Investigations is looking into matter More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Ukraine Schools Resume Classes, Donate to Government Forcesi
X
September 02, 2014 12:58 PM
A new school year has started in Ukraine but thousands of children in the war-torn east are unable to attend because of ongoing clashes with pro-Russia rebels. In Ukraine's capital, patriotic education has become the norm along with donations to support injured security forces fighting to take back rebel-held areas. VOA's Daniel Schearf reports from Kyiv.
Video

Video Ukraine Schools Resume Classes, Donate to Government Forces

A new school year has started in Ukraine but thousands of children in the war-torn east are unable to attend because of ongoing clashes with pro-Russia rebels. In Ukraine's capital, patriotic education has become the norm along with donations to support injured security forces fighting to take back rebel-held areas. VOA's Daniel Schearf reports from Kyiv.
Video

Video US Detainees Want Negotiators for Freedom in North Korea

The three U.S. detainees held in North Korea were permitted to speak with foreign media Monday. The government of Kim Jong Un restricted the topics of the questions, and the interviews in Pyongyang were limited to five minutes. Each of the men asked Washington to send a representative to Pyongyang to secure his release. VOA’s Carolyn Presutti has our story.
Video

Video Internet, Technology Offer New Tools for Journalists

The Internet and rapidly evolving technology is quickly changing how people receive news and how journalists deliver it. There are now more ways to tell a story than ever before. One school in Los Angeles is teaching the next generation of journalists with the help of a state-of-the-art newsroom. Elizabeth Lee has this report.
Video

Video Turkmen From Amerli Describe Survival of IS Siege

Over the past few weeks, hundreds of Shi'ite Turkmen have fled the town of Amerli seeking refuge in the northern city of Kirkuk. Despite recent military gains after U.S. airstrikes that were coordinated with Iraqi and Kurdish forces, the situation remains dire for Amerli’s residents. Sebastian Meyer went to Kirkuk for VOA to speak to those who managed to escape.
Video

Video West Africa Ebola Vaccine Trials Possible by Early 2015

A U.S. health agency is speeding up clinical trials of a possible vaccine against the deadly Ebola virus that so far has killed more than 1,500 people in West Africa. If successful, the next step would be a larger trial in countries where the outbreak is occurring. VOA's Carol Pearson has more.
Video

Video Survivors Commemorate 70th Anniversary of Nazi Liquidation of Jewish Ghetto

When the German Nazi army occupied the Polish city of Lodz in 1939, it marked the beginning of a long nightmare for the Jewish community that once made up one third of the population. Roughly 200,000 people were forced into the Lodz Ghetto. Less than 7,000 survived. As VOA’s Kane Farabaugh reports, some survivors gathered at the Union League Club in Chicago on the 70th anniversary of the liquidation of the Lodz Ghetto to remember those who suffered at the hands of the Nazi regime.
Video

Video Cost to Raise Child in US Continues to Rise

The cost of raising a child in the United States continues to rise. In its latest annual report, the U.S. Department of Agriculture says middle income families with a child born in 2013 can expect to spend more than $240,000 before that child turns 18. And sending that child to college more than doubles that amount. VOA’s Deborah Block visited with a couple with one child in Alexandria, Virginia, to learn if the report reflects their lifestyle.
Video

Video Chaotic Afghan Vote Recount Threatens Nation’s Future

Afghanistan’s troubled presidential election continues to be rocked by turmoil as an audit of the ballots drags on. The U.N. says the recount will not be completed before September 10. Observers say repeated disputes and delays are threatening the orderly transfer of power and could have dangerous consequences. VOA correspondent Meredith Buel reports.

AppleAndroid